Abbott Recalls 13 Million Pregnancy Tests Worldwide Over False Positives

Abbott has recalled more than 13 million rapid pregnancy tests distributed to hospitals due to a risk of false-positive results at low hCG levels. The tests went to the U.S., Canada, the U.K. and 12 other countries; customers may keep using the product.

• Recall initiated Aug. 20, FDA notice posted Sept. 25
• Tests detect low hCG, causing false positives in non-pregnant people
• About 2,800 units recalled in Canada by Innovacon
• Sold under Fisher Scientific, McKesson, Cardinal Health and other brands